ThisiscontentfromClinicalKey
Chronic Pain Management in Children
Sign up for your free ClinicalKey trial today! Your first step in getting the right answers when you need them.
In addition to IIPT, which is resource-intensive and requires a large team, lower intensity outpatient programs have been introduced to address chronic pain in children.58,59 Such lower intensity options may provide a lower cost alternative for some children or help to bridge the gap between traditional outpatient management and IIPT
Class | Example medications | Indications | Side effects | Evidence per Cochrane Review |
---|---|---|---|---|
As-needed medications | ||||
Acetaminophen | Acetaminophen | Acute pain, adjunctive treatment | Hepatic injury | No eligible studies to include |
NSAIDs | Ibuprofen, naproxen | Acute pain, inflammatory conditions, abortive headache treatment | GI effects, kidney injury, bleeding disorders, hypertension | Small number of studies, insufficient data for analysis |
Muscle relaxants | Methocarbamol, cyclobenzaprine, tizanidine, badofen | Myofascial pain, spasmodic pain | Sedation, nausea, dizziness, serotonin syndrome for cyclobenzaprine | No review performed |
Opioids | Morphine, oxycodone, hydromorphone | Acute pain, postsurgical pain | Sedation, nausea, dependence, addiction | No eligible studies to include |
Daily medications | ||||
Antiepileptics | Gabapentin, pregabalin, oxcarbazepine | Neuropathic pain, widespread pain, primary pain disorders | Somnolence, altered mood, weight gain | Small number of studies, insufficient data for analysis |
Antidepressants | Amitripyline and other TCAs Duloxetine and other SNRIs | Neuropathic pain, headache prophylaxis, abdominal pain, widespread pain, primary pain disorders Neuropathic pain, widespread pain, primary pain disorders | Somnolence, altered mood, dry mouth, prolonged QT interval (QTc), risk of serotonin syndrome Altered mood, nausea, risk of serotonin syndrome | Small number of studies, insufficient data for analysis |
Cookies are used by this site. To decline or learn more, visit our cookie notice.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.